Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commercial

Set Alert for Commercial

Q3 Earnings Spotlight: Abiomed Shines Among Cardiology Device-Makers

Reported sales and earnings from the publicly traded cardiovascular device companies show strong performance across the sector, spurred by new approvals and clinical trials, in the quarter that ended Sept. 30. Here's a recap of results from the cardio device companies that have reported so far, including Abbott, Abiomed, and Reva.

Commercial Cardiovascular Financing
Advertisement

Companies

Set Alert for Companies

Latest From Companies

QUOTED. Nov. 13, 2018. Avi Fischer.

Abbott Laboratories pointed to success in its electrophysiology device business last quarter, driven by multiple products including the Confirm Rx insertable cardiac arrhythmia monitor, which the firm says is the thinnest in class, and is smartphone-compatible for more direct patient engagement. See what Abbott VP Ari Fischer says about it here.

Quoted Commercial

Q3 Earnings Spotlight: Ortho Firms Show Mixed Results Against US Pricing Pressure

Reported sales and earnings from the publicly traded orthopedics device companies showed mix results during the third quarter of 2018. NuVasive was the star performer in the group while, on the other end of the spectrum, Stryker continued to show strong growth across most its businesses, while Johnson & Johnson's orthopedic device revenue was near flat.</p>

Orthopedics Deals

Q3 Earnings Spotlight: Roche, Abbott, bioMérieux Lead IVD Company Results

Medtech Insight highlights Q3 2018 results from some of the leading IVD players. In this edition, we spotlight some of the big companies including Roche Diagnostics, Thermo Fisher Scientific, bioMérieux, and Becton Dickinson.

Commercial In Vitro Diagnostics
See All

Deals and Financings

Set Alert for Deals

Latest From Deals

Q3 Earnings Spotlight: Ortho Firms Show Mixed Results Against US Pricing Pressure

Reported sales and earnings from the publicly traded orthopedics device companies showed mix results during the third quarter of 2018. NuVasive was the star performer in the group while, on the other end of the spectrum, Stryker continued to show strong growth across most its businesses, while Johnson & Johnson's orthopedic device revenue was near flat.</p>

Orthopedics Deals

QUOTED. Nov. 8, 2018. John Damgaard.

RedMed Inc. is continuing to invest aggressively in its "software-as-a-service" offerings with the addition of MatrixCare, a provider of long-term post-acute care software. See what MatrixCare CEO John Damgaard said about it here.

Quoted Deals

Medtech Money Flow: M&A And VC Deals, Oct. 29-Nov. 4, 2018

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, between Oct. 29 and Nov. 4, 2018.  

M & A Financing
See All

Market Access

Set Alert for Market Access

Latest From Market Access

Medicare Allows Use Of Hospital Outreach Lab Pay Data; Industry Applauds, But Still Sues

The clinical laboratory industry praised the US Centers for Medicare and Medicaid Services for making changes in its final Clinical Laboratory Fee Schedule rule to allow more data from hospital outreach labs to be considered in setting laboratory test pay rates. But lab advocates are still pursuing a lawsuit and pushing for legislative reforms.

Reimbursement Regulation

Ukraine Steps Up Plan For 'Professional' Procurement Agency

Ukraine’s central procurement agency for medicines and medical devices is set to become fully operational in 2020.
Ukraine Market Access

Focus More On Patients, Less On Hospitals, Experts Tell Device Companies

Devices that collect and communicate patient data present opportunities for device-makers to have a closer relationship with end-users, but most device companies have little experience working directly with patients. Device firms need to close this gap by seeing the patients who use their devices as their primary customers, rather than just focusing on intermediaries like doctors, hospitals, and payers, industry experts tell Medtech Insight.

Digital Health Business Strategies
See All

Market Intelligence

Set Alert for Market Intelligence

Latest From Market Intelligence

Market Intel: Apps for Epilepsy, Steps for Health, Meditation Guides, Mouth Labs Cross Digital Divide For Better Health

Startups at the convergence of technology and biomedical innovations showcased compelling innovations at this week's Exponential Medicine conference in San Diego. This article offers a roundup of new devices targeting a wide range of applications from neurology, cardiology, chronic diseases and wellness.

Innovation Analysis

Market Snapshot: Ventilators & Pulmonary Function Assessment Products Market Sees Moderate Growth

The global market for ventilators and pulmonary function assessment products is expected to reach $1.7bn by 2022, driven in large part by rising incidences of pulmonary diseases in the elderly population. The larger market segment of diagnostics spirometry products will grow at a faster rate than the smaller pulmonary function testing and disposable products market, driven by an emphasis of disease prevention via early diagnosis in outpatient and alternate care settings. Check out our infographic on the market.

Respiratory Diagnostics

Market Intel: Martin Leon's TAVR Technology Tour Of The Future

Transcatheter aortic valve replacement pioneer Martin Leon discussed what is coming down the pike for technologies in the TAVR and heart valve device space at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference in San Diego. Here is a run-down of what he highlighted, including AI-driven technologies that promise to improve patient access and outcomes. This is the first of a two-part series focusing on innovations in interventional cardiology. 

Surgical Procedures Cardiovascular
See All

Appointments

Set Alert for Appointments

Latest From Appointments

Execs On The Move: Coloplast, EOS, Notal Hire CEOs From The Inside

Promotions bring execs to the top spots at ostomy and wound-care specialist Coloplast AS, imaging solutions and ortho surgical care company EOS Imaging, and ophthalmics AI firm Notal Vision. Those and more recent medtech personnel moves.

Appointments Commercial

Execs On The Move: Changes In Management Positions At Danaher And Johnson & Johnson

This week, a new corporate development senior VP arrives at clinical and research diagnostics firm Abcam, a VP opts out of business development post at Danaher to strategize for Agilent Tech, and a supply chain exec departs J&J.

Appointments Commercial

Execs On The Move: Chair Changes At InvitroCue, Predictive Technology And B. Braun

New chairs of InvitroCue's medical advisory board, Predictive Technology's clinical advisory board and B. Braun Melsungen's management board.

Appointments Medical Device
See All
UsernamePublicRestriction

Register